Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78,166 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer.
Wang J, Lai X, Yao H, Yang H, Cao X, Wang X, Wang Y, Nian W, Zheng X, Mai Q, Liu A, Lv X, Bi X, Chen J, Wu J, Ye S. Wang J, et al. Among authors: wu j. J Cancer Res Clin Oncol. 2025 Jan 22;151(1):41. doi: 10.1007/s00432-025-06086-0. J Cancer Res Clin Oncol. 2025. PMID: 39838193
Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial.
Loi S, Salgado R, Curigliano G, Romero Díaz RI, Delaloge S, Rojas García CI, Kok M, Saura C, Harbeck N, Mittendorf EA, Yardley DA, Suárez Zaizar A, Caminos FR, Ungureanu A, Reinoso-Toledo JG, Guarneri V, Egle D, Ades F, Pacius M, Chhibber A, Chandra R, Nathani R, Spires T, Wu JQ, Pusztai L, McArthur H. Loi S, et al. Among authors: wu jq. Nat Med. 2025 Jan 21. doi: 10.1038/s41591-024-03414-8. Online ahead of print. Nat Med. 2025. PMID: 39838118
Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.
Zhang X, Lau HC, Ha S, Liu C, Liang C, Lee HW, Ng QW, Zhao Y, Ji F, Zhou Y, Pan Y, Song Y, Zhang Y, Lo JCY, Cheung AHK, Wu J, Li X, Xu H, Wong CC, Wong VW, Yu J. Zhang X, et al. Among authors: wu j. Nat Metab. 2025 Jan 21. doi: 10.1038/s42255-025-01215-y. Online ahead of print. Nat Metab. 2025. PMID: 39838065 No abstract available.
Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomas.
Wang J, Lou Y, Peng X, Ye M, Cao W, Wu J, Yan Z, Zhao X, Zhou Y, Zheng C, Wei X, Chen Q, Hu C, Zhang M, Qu L, Chen Z, Fu Q, Wang W, Li J, Zhang Q, Liang T. Wang J, et al. Among authors: wu j. Transl Oncol. 2025 Jan 20;53:102275. doi: 10.1016/j.tranon.2025.102275. Online ahead of print. Transl Oncol. 2025. PMID: 39837058
78,166 results
You have reached the last available page of results. Please see the User Guide for more information.